Yili Chuannig Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -37.19% vs 45.63% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -59.78% vs 92.06% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,033.60",
          "val2": "1,645.50",
          "chgp": "-37.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "373.10",
          "val2": "648.90",
          "chgp": "-42.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.60",
          "val2": "10.10",
          "chgp": "4.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "166.40",
          "val2": "413.70",
          "chgp": "-59.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "219.70%",
          "val2": "311.70%",
          "chgp": "-9.20%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.38% vs 26.32% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 48.88% vs 128.58% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,678.60",
          "val2": "4,756.70",
          "chgp": "19.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,295.90",
          "val2": "1,737.30",
          "chgp": "32.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "62.40",
          "val2": "89.20",
          "chgp": "-30.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,400.40",
          "val2": "940.60",
          "chgp": "48.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "305.80%",
          "val2": "249.40%",
          "chgp": "5.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

1,033.60

1,645.50

-37.19%

Operating Profit (PBDIT) excl Other Income

373.10

648.90

-42.50%

Interest

10.60

10.10

4.95%

Exceptional Items

0.00

0.30

-100.00%

Consolidate Net Profit

166.40

413.70

-59.78%

Operating Profit Margin (Excl OI)

219.70%

311.70%

-9.20%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -37.19% vs 45.63% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -59.78% vs 92.06% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

5,678.60

4,756.70

19.38%

Operating Profit (PBDIT) excl Other Income

2,295.90

1,737.30

32.15%

Interest

62.40

89.20

-30.04%

Exceptional Items

0.00

-1.20

100.00%

Consolidate Net Profit

1,400.40

940.60

48.88%

Operating Profit Margin (Excl OI)

305.80%

249.40%

5.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 19.38% vs 26.32% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 48.88% vs 128.58% in Dec 2023

All Annual Results